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Viral Infection Results in Massive
CD8 T Cell Expansion and Mortality
in Vaccinated Perforin-Deficient Mice
cranial (IC) infection of adult mice with lymphocytic
choriomeningitis virus (LCMV), which results in CD8
T cell-mediated immunopathology in the brain and even-
tual death (Kagi et al., 1994; Walsh et al., 1994). Lethal
immunopathology in this model depends on perforin-
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mediated CD8 T cell cytolysis (Kagi et al., 1994; WalshIowa City, Iowa 52242
et al., 1994) and is also affected by the virulence and
dosage of the LCMV strain (Oehen et al., 1992; Smelt
et al., 2001).Summary
Effective vaccination strategies generally evoke adap-
tive immune responses similar to those found after infec-Perforin-mediated cytotoxicity is essential for clear-
tion. However, vaccination with recombinant vacciniaance of primary LCMV infection. BALB/c-perforin-defi-
virus expressing LCMV proteins resulted in CD8 T cell-cient (PKO) mice survived LCMV infection by deleting
mediated fatal meningitis after IC infection with strainsNP118-specific CD8 T cells whereas vaccination of
or doses of LCMV that did not evoke lethal immunopa-PKO mice with Listeria expressing NP118 generated a
thology in naive hosts (Oehen et al., 1992). Thus, whilestable memory CD8 T cell population. However, 85%
vaccination generally enhances antimicrobial immunity,of vaccinated BALB/c-PKO mice died after LCMV
it has the potential to be harmful under certain circum-infection. Mortality was associated with enormous
stances. Evidence to support this notion is not limited toexpansion of NP118-specific CD8 T cells in both
experimental models, as vaccination against respiratorylymphoid and nonlymphoid tissues and aberrant CD8
syncytial virus and measles virus has been associatedT cell cytokine production. Depletion of CD8 T cells or
with exacerbation of disease in humans (Fulginiti et al.,treatment with anti-IFN antibody rescued vaccinated
1967; Kim et al., 1969).mice from mortality. Thus, perforin was essential for
Intraperitoneal infection of wild-type (WT) mice withresistance to secondary LCMV infection, and, in the
LCMV strain Armstrong (Arm) results in vigorous CD8absence of perforin, vaccination resulted in lethal dis-
T cell expansion (Butz and Bevan, 1998; Homann et al.,ease mediated by dysregulated CD8 T cell expansion
2001; Murali-Krishna et al., 1998) and perforin-depen-and cytokine production.
dent clearance of the virus without overt clinical symp-
toms. Perforin-deficient mice fail to clear LCMV ArmIntroduction
and develop chronic infections with occasional mortality
(Matloubian et al., 1999). In contrast, infection of WTEarly events after primary infection or vaccination pro-
mice with LCMV clone 13 results in exhaustion of LCMV-gram antigen (Ag)-specific CD8 T cells to expand and
specific CD8 T cells and chronic infection usually with-differentiate into effector cells (Badovinac et al., 2002;
out mortality. Interestingly, perforin-deficient mice ex-Bevan and Fink, 2001; Kaech and Ahmed, 2001; Mer-
hibit reduced CD8 T cell exhaustion and increasedcado et al., 2000; van Stipdonk et al., 2001) that are
mortality after infection with LCMV clone 13 and DOCILEcapable of cytolysis and production of cytokines such
(Gallimore et al., 1998; Matloubian et al., 1999), sug-as IFN and TNF (Harty et al., 2000). Recently, we
gesting a role for perforin in the exhaustion process.showed that CD8 T cell contraction to memory levels
Additionally, we found increased CD8 T cell expansionis also programmed and independent of the duration of
in perforin-deficient compared to WT mice after infec-
infection or Ag display (Badovinac et al., 2002). As a
tion with attenuated Listeria monocytogenes (LM) (Bad-
consequence of their increased number and perhaps
ovinac et al., 2000b). Together, the results suggest that,
different threshold(s) of activation, memory CD8 T cells in addition to a major role in cytolysis of infected cells,
are poised for rapid responses and early control of perforin may also regulate important aspects of the
pathogens after reinfection. It is apparent that contrac- CD8 T cell response (Harty and Badovinac, 2002). Res-
tion of the secondary response is also programmed olution of this issue has direct relevance for under-
(Badovinac et al., 2002); however, contraction of the standing the pathogenesis of familial hemophagocytic
secondary CD8 T cell response occurs over several lymphohistiocytosis syndromes—uniformly fatal dis-
weeks rather than several days as observed in contrac- eases associated with recurrent viral infections, as at
tion of the primary response to infection (Badovinac et least some afflicted individuals are deficient in perforin
al., 2002; Grayson et al., 2002). (de Saint Basile and Fischer, 2001; Stepp et al., 1999;
In general, cytolysis and cytokine production by ef- Trapani and Smyth, 2002).
fector and memory CD8 T cells are tightly regulated The requirement for perforin-mediated cytolysis in re-
by the presence of Ag, likely as a mechanism to minimize sistance to primary infection with LCMV is well docu-
immunopathology (Slifka and Whitton, 2000b). However, mented (Kagi et al., 1996). Perforin-deficient mice also
clear evidence from experimental models shows that are impaired in clearance of primary infection with viru-
the CD8 T cell response to infection can be associated lent LM (Jensen et al., 1998; Kagi et al., 1994). However,
with lethal immunopathology. A classic example is intra- vaccination of perforin-deficient mice with attenuated
LM generates CD8 T cells that provide enhanced resis-
tance to infection (White et al., 1999). In addition, adop-*Correspondence: john-harty@uiowa.edu
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tive transfer studies with perforin-deficient CD8 T cell
lines provide clear evidence of perforin-independent
pathways of protection against LM infection (White and
Harty, 1998). Similarly, IFN- and TNF-deficient mice are
extremely sensitive to virulent LM but can be vaccinated
with attenuated LM to generate high level CD8 T cell-
mediated resistance against secondary infection (Harty
and Bevan, 1995; White et al., 2000). Together, these
results demonstrate that vaccination can overcome the
absence of effector molecules that are critical for resis-
tance to primary infection, at least in the LM model.
However, the generality of this observation for different
pathogens, particularly viruses, is unknown. Since clear-
ance of primary LCMV infection is absolutely dependent
on perforin, it is the most stringent model to determine
whether vaccination generates memory CD8 T cells
that can overcome perforin deficiency and control viral
infection. In addition, the impact of perforin deficiency
on regulation of the secondary CD8 T cell response to
infection remains to be determined. In this study, we
analyzed the outcome of LCMV infection and the nature
of the secondary CD8 T cell response in vaccinated
perforin-deficient mice.
Results
NP118-Specific CD8 T Cell Homeostasis after Viral
Figure 1. Disappearance of NP118-Specific CD8 T Cells after LCMVand Bacterial Infections in the Absence
Infection in Perforin-Deficient Miceof Perforin
BALB/c (WT, H-2d) and perforin-deficient mice (BALB/c-PKO, H-2d)Vaccination of BALB/c (H-2d) mice with recombinant
were infected (A) i.p. with 2  105 pfu LCMV-Arm or (B) 1  106
(r)LM-expressing the LCMV NP118 epitope generated cfu of Att LM-NPs, and NP118-specific CD8 T cells were measured
memory CD8 T cells that protected against LCMV chal- by Ld(NP118) tetramers and/or intracellular IFN staining at the indi-
lenge (Shen et al., 1998). We wished to use the same cated days after challenge. Dashed line represents the limit of detec-
tion. Survival was 100% in all groups of mice (two to four mice persystem to determine whether vaccination could protect
time point).against LCMV infection in the absence of perforin. How-
ever, all published studies on LCMV infection in the
absence of perforin used B6 (H-2b) perforin-deficient
(PKO) mice (Gallimore et al., 1998; Kagi et al., 1994, Thus, perforin was essential for clearance of LCMV in
mice expressing either H-2b or H-2d MHC molecules.1999; Matloubian et al., 1999; Walsh et al., 1994). Thus,
we first needed to determine the course of infection and However, perforin was not essential for exhaustion of
NP118-specific CD8 T cells in BALB/c-PKO mice. TheCD8 T cell response in BALB/c-PKO mice after primary
LCMV infection. We infected BALB/c and BALB/c-PKO reason(s) for the strain differences are unknown but may
relate to differences in the complexity of the CD8 T cellmice with LCMV-Arm and measured the CD8 T cell
response to the NP118 epitope using tetrameric MHC response (four strong LCMV epitopes in B6 mice com-
pared to one very dominant epitope in BALB/c) or toclass I-peptide complexes (Ld [NP118]) (Altman et al.,
1996) or intracellular cytokine staining (ICS) for IFN the influence of background genes. While resolution of
this issue will be of interest, the major point from this(Badovinac and Harty, 2000) (Figure 1A). As we recently
reported, the expansion and early contraction of NP118- experiment was that BALB/c-PKO failed to clear primary
LCMV infection but exhibited 100% survival, which cor-specific CD8 T cells was similar in BALB/c and BALB/
c-PKO mice, despite high virus titers in the spleen of related with exhaustion of NP118-specific CD8 T cells.
In contrast to LCMV infection, perforin was not re-PKO mice (106 pfu/g at day 12 postinfection [Badovi-
nac et al., 2002]). However, we detected no NP118-spe- quired for resistance to primary infection with actA-defi-
cient LM, which were cleared from BALB/c and BALB/cific CD8T cells in BALB/c-PKO mice at 85 days postin-
fection, with either tetramer staining or ICS, whereas a c-PKO mice with similar kinetics (Badovinac et al.,
2000b; Harty et al., 2000; White et al., 1999). Immuniza-large population of NP118-specific memory CD8 T cells
were detected at the same time in BALB/c mice (Figure tion of BALB/c-PKO mice with an actA-deficient strain
of LM that expressed the LCMV-derived NP118 epitope1A and Murali-Krishna et al., 1998). Furthermore, the
significant mortality reported after LCMV infection of (Att LM-NPs) (Shen et al., 1998; Tvinnereim et al., 2002)
generated vigorous expansion of NP118-specific CD8 TH-2b PKO mice (Matloubian et al., 1999) was not ob-
served after LCMV infection of BALB/c-PKO mice as cells, which exhibited normal contraction to a substan-
tial number (105 /spleen) of functional (IFN-producing)100% (40/40 from multiple experiments) of these mice
survived 100 days p.i. Finally, BALB/c-PKO mice still NP118-specific memory CD8 T cells 85 days after chal-
lenge (Figure 1B). We have previously reported similarharbored virus at day 100 p.i. (1 105 pfu/g spleen).
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kinetics for CD8 T cell responses to endogenous LM
epitopes (Badovinac et al., 2000b). The numbers of
NP118-specific CD8 T cells in BALB/c-PKO mice were
virtually identical from day 35 to day 85 postinfection,
demonstrating normal maintenance of Ag-specific
memory CD8 T cells in BALB/c-PKO mice after Att LM-
NPs infection (Figure 1B).
These data demonstrate that exhaustion of NP118-spe-
cific CD8 T cells in BALB/c-PKO mice was a function
of LCMV infection and not the specific epitope. In addi-
tion, the results showed that functional NP118-specific
memory CD8 T cells can be generated in BALB/c-PKO
mice by immunization with Att LM-NPs.
CD8T Cell Vaccination of Perforin-Deficient Mice
We next asked whether vaccination altered the outcome
of LCMV infection in the absence of perforin. BALB/
c-PKO mice were immunized with either Att LM-NPs or
a control strain Att LM, which did not express the NP118
epitope (Figure 2A). The total numbers of Ag-specific
CD8 T cells in the spleens were determined 37 days
later, using ICS for IFN (Figures 2B and 2C). CD8
T cells specific for the LM-derived H-2Kd restricted
LLO91-99 epitope (Pamer et al., 1991) were detected after
Att LM and Att LM-NPs immunization (Figures 2B and
2C). Att LM-NPs infection also evoked a substantial level
of NP118-specific memory CD8 T cells (2  105  0.4 
105 /spleen), which was absent in Att LM immunized
mice (Figures 2B and 2C).
Immunized BALB/c-PKO mice were challenged with
LCMV-Arm at day 37 postbacterial infection. All Att LM
immunized BALB/c-PKO mice survived infection and
exhibited no overt signs of illness. In striking contrast,
all Att LM-NPs vaccinated BALB/c-PKO mice died by
day 8 post-LCMV challenge (Figure 2D). In other experi-
ments, transfer of BALB/c-derived NP118-specific CD8
T cells into BALB/c-PKO hosts resulted in survival after
LCMV infection and generation of stable NP118-specific
memory (data not shown). Thus, perforin-deficient NP118-
specific memory CD8 T cells failed to protect BALB/
c-PKO mice from LCMV, and their presence correlated
with mortality rather than survival after infection.
Enormous Expansion of Ag-Specific CD8
T Cells after LCMV Challenge in Vaccinated
BALB/c-PKO Mice
To address the mechanism(s) responsible for LCMV-
induced mortality in Att LM-NPs vaccinated mice, we
analyzed Ag-specific CD8 T cell expansion after LCMV
challenge. Naive and Att LM immune BALB/c-PKO mice
Figure 2. Vaccinated Perforin-Deficient Mice Succumb to LCMVhad substantial numbers (several million) of NP118-spe- Challenge
cific CD8 T cells at day 5 post-LCMV infection as de-
(A) Experimental design. BALB/c-PKO mice were infected i.v. withtected by tetrameric MHC class I-peptide complexes
1  106 cfu of Att LM or Att LM-NPs. At day 37 postinfection mice
(Ld [NP118]) (Figure 3). In sharp contrast, Att LM-NPs vac- were challenged i.p. with 2  105 pfu LCMV-Arm.
cinated BALB/c-PKO mice had an enormous number of (B) Frequency of LLO91-99 and NP118-specific CD8 T cells from repre-
sentative mice at day 37 post-LM challenge as determined by ICS.NP118-specific CD8 T cells (108 /spleen, Figure 3B) at
Numbers represent the percent of Ag-specific CD8 T cells thatday 5 after LCMV challenge. Almost 50% of all spleen
produce IFN in the absence (no peptide) or in the presence of thecells in these mice were CD8- and NP118-specific (Fig-
indicated peptides.ure 3A). Strikingly, 85%–90% of all CD8 T cells in the
(C) Total number (mean  SD) and frequencies of Ag-specific CD8
spleen were NP118-specific (Figure 3A). To the best of T cells per spleen from three mice. Total number of NP118-specific
our knowledge this is the highest in vivo frequency and CD8 T cells obtained after Att LM-NP infection was 2.3  0.4 
105 cells/spleen. ND, not detectable.total number of single epitope-specific CD8 T cells
(D) Survival of BALB/c-PKO mice after LM and LCMV infections.detected in a nontransgenic system. The number of
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Figure 3. Enormous Expansion of Perforin-
Deficient NP118-Specific CD8 T Cells in the
Spleen after LCMV Challenge
BALB/c-PKO mice that have been previously
immunized with Att LM, Att LM-NPs, or naive
controls were infected with LCMV-Arm.
(A) At day 5 post-LCMV challenge, the fre-
quencies of NP118-specific CD8 T cells in the
spleen were determined by MHC class I tetra-
mer (Ld[NP118]) staining in representative mice.
Numbers inside the Ld(NP118) versus CD8 dot
plots represent percentages of all CD8 T cells/
percentage of NP118-specific CD8 T cells
among all splenocytes. The numbers inside
the number of cells versus Ld(NP118) histo-
grams represent the percentage of CD8
T cells that stained with Ld(NP118) tetramers.
(B) Total number (mean  SD) of NP118-spe-
cific CD8 T cells per spleen from two mice. A
representative experiment of three is shown.
NP118-specific CD8T cells in LM-NPs vaccinated BALB/ to 1 out of 3 lymphocyte gated cells (liver), were ob-
served in tissues from vaccinated BALB/c mice at dayc-PKO mice far exceeded that reported for secondary
responses to LCMV in immune BALB/c mice (Grayson 6 after LCMV-Arm infection (Figure 4). The frequency of
NP118-specific cells out of all CD8 T cells in variouset al., 2002). Thus, the absence of perforin resulted in an
enormous secondary response of NP118-specific CD8 tissues of BALB/c mice ranged from 33%–80%. In con-
trast, 90% of all CD8 T cells detected in various or-T cells in the spleen after LCMV infection. Importantly,
this was associated with mortality. gans of vaccinated BALB/c-PKO mice were specific for
the NP118 epitope at day 6 after LCMV infection (FigureAfter infection, Ag-specific CD8 T cells are present
in nonlymphoid as well as in lymphoid tissues (Marshall 4B), resulting in 1.5 to 30 times more NP118-specific CD8
T cells, depending on the tissue, than vaccinatedet al., 2001; Masopust et al., 2001). One possible expla-
nation for the enormous NP118-specific CD8 T cell num- BALB/c mice (Figure 4C). This estimation was based on
frequency of NP118-specific CD8 T cells rather than totalbers in the spleen was a failure of these cells to migrate
into tissues. To address this issue, we isolated lympho- numbers due to variability in recovery of lymphocytes
from organs in different mice. However, in no case werecytes and measured NP118-specific CD8 T cells in vari-
ous tissues of Att LM-NPs vaccinated BALB/c and fewer lymphocytes recovered from vaccinated BALB/
c-PKO organs; thus, these animals contained substan-BALB/c-PKO mice after LCMV-Arm challenge (Figure
4). Robust NP118-specific CD8 T cell responses, ranging tially more nonlymphoid NP118-specific CD8 T cells than
vaccinated BALB/c mice. From these data we concludefrom 1 out of 300 lymphocyte gated cells (bone marrow)
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Figure 4. Expansion of Wild-Type and Perforin-Deficient NP118-Specific CD8 T Cells in the Lymphoid and Nonlymphoid Tissues after LCMV
Challenge
WT and BALB/c-PKO mice were infected with Att LM-NPs and at day 58 p.i. mice were challenged with LCMV-Arm. At day 6 post-LCMV
infection lymphocytes from the indicated tissues were subjected to MHC class I tetramer (Ld[NP118]) staining.
(A) The numbers inside the Ld(NP118) versus CD8 contour plots represent the percentage of NP118-specific CD8 T cells among all lymphocytes.
(B) The numbers inside the number of cells versus Ld(NP118) histograms represent the percentage of CD8 T cells that stained with Ld(NP118)
tetramers. Data in (A) and (B) are representative of two mice in the experiment.
(C) Approximate fold increase in frequencies of Ld(NP118)-positive cells in BALB/c-PKO mice compared to WT mice. PBL, peripheral blood
leukocytes; BM, bone marrow; LU, lung; KI, kidney; LI, liver; SP, spleen.
that the enormous expansion of NP118-specific CD8 class I-peptide tetramers (Figures 3 and 4). To determine
whether cells detected by tetramer staining were func-T cells in vaccinated BALB/c-PKO spleens was not a
consequence of failure by these cells to migrate to tis- tional, splenocytes from vaccinated BALB/c and BALB/
c-PKO mice were analyzed for the ability to producesues. In addition, a substantial number of NP118-specific
CD8 T cells were located in nonlymphoid tissues, and IFN after 6 hr incubation in brefeldin A (BfA) in the
these cells may have contributed to mortality in vacci- presence or absence of NP118 peptide (Figure 5).
nated BALB/c-PKO mice. Similar frequencies of Ag-specific CD8 T cells were
detected by tetramer and ICS for IFN at day 5 after
LCMV infection of vaccinated BALB/c mice (Figures 5APhenotypic and Functional Comparison
of Ag-Specific CD8 T Cells after LCMV and 5B). Importantly, NP118-specific CD8 T cells from
BALB/c mice did not produce IFN in the absence ofInfection in BALB/c and BALB/c-PKO Mice
The frequencies of CD8 T cells responding to NP118 peptide stimulation. Thus, regulation of direct ex vivo
IFN production by NP118-specific CD8 T cells inwere determined by phenotypic assessment using MHC
Immunity
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Figure 5. IFN Production by Wild-Type and Perforin-Deficient NP118-Specific CD8 T Cells after LCMV Infection
WT and BALB/c-PKO mice were infected with Att LM-NPs and at day 58 p.i. mice were challenged with LCMV-Arm.
(A) At day 5 post-LCMV challenge, the frequencies of NP118-specific CD8 T cells in the spleen were determined by MHC class I tetramer
(Ld[NP118]) staining. The numbers inside the Ld(NP118) versus CD8 dot plots represent the percentage of NP118-specific CD8 T cells among all
splenocytes.
(B) The same mice as in (A) were analyzed for Ag-specific IFN production in the absence (no peptide) or in the presence of NP118 peptide
after 6 hr incubation in the presence of BfA. The numbers inside the IFN versus CD8 contour plots represent the percentage of NP118-specific
CD8 T cells among all splenocytes.
(C) The numbers inside the number of cells versus Ld(NP118) histograms represent the percentage of CD8 T cells that stained with IFN in
the presence or absence of NP118 peptide stimulation.
BALB/c mice was Ag dependent (Badovinac et al., specific CD8 T cell response was maintained at later
time points and all of the mice died by day 8 post-LCMV2000a; Slifka et al., 1999). In contrast, cytokine produc-
tion by perforin-deficient NP118-specific CD8 T cells challenge (Figure 6B). If we assume104 NP118-specific
CD8T cells at day 2 postinfection (an upper limit, Figurewas substantially different. In the absence of peptide
stimulation one out of three antigen-specific CD8 6B) and that none of the NP118-specific CD8 T cells
would die or leave the spleen, then these cells dividedT cells (23% compared to 76% in peptide-stimulated
cells, Figure 5C) produced high levels of IFN after 6 hr 13 times over the ensuing 72 hr to reach 108 NP118-
specific CD8 T cells/spleen at day 5 post-LCMV infec-of in vitro incubation. These data demonstrate aberrant
regulation of direct ex vivo cytokine production by NP118- tion. This represents a doubling rate of 5.5 hr (death
and emigration of Ag-specific CD8 T cells from thespecific CD8 T cells from LCMV-infected BALB/c-PKO
mice. spleen would decrease the doubling time), a rate that
is even faster than that suggested for the expansion of
NP118-specific CD8 T cells after primary infection ofKinetics of Ag-Specific CD8 T Cell Expansion BALB/c mice (Goldrath and Bevan, 1999; Murali-Krishna
in Vaccinated Perforin-Deficient Mice et al., 1998). These data revealed dramatic expansion
after LCMV Infection NP118-specific CD8 T cells over the short period of timeWe next addressed the kinetics of the CD8 T cell re- immediately preceding the onset of fatal disease.
sponse after LCMV infection of vaccinated BALB/c-PKO
mice. More than 10 weeks after vaccination with Att LM-
NPs, BALB/c-PKO mice contained 1  105  0.4  105 Cytokine Production by Perforin-Deficient
NP118-Specific CD8 T CellsNP118-specific CD8 T cells in the spleens. Two days
after LCMV infection, we were unable to find NP118-spe- After direct ex vivo peptide stimulation most WT Ag-
specific CD8 T cells that made IFN also make TNFcific CD8 T cells (detection limit 104 cells/spleen),
either by tetramer staining or functional assays for cyto- (Badovinac and Harty, 2000; Slifka and Whitton, 2000a).
Direct ex vivo IFN production continued while Ag waskine production (Figures 6A–6C). The reason for this
decline is not known; however, similar results were re- present but rapidly ceased upon Ag removal. In contrast,
TNF production by the same Ag-specific cells ceasedported after high-dose secondary challenge with LM
(Busch et al., 2000). At day 4 after LCMV infection 20% after 3–4 hr of stimulation, whether or not the Ag was
removed (Badovinac et al., 2000a). Consistent with theof splenic CD8 T cells stained with Ld(NP118) tetramers.
One day later, more than 80% of CD8 T cells were results in Figure 5, a substantial fraction of NP118-specific
CD8 T cells (50% of all CD8 T cells in these animals)specific for NP118 (Figure 4A), representing 108 cells/
spleen (Figure 6B). The elevated frequency of the NP118- produced IFN even without in vitro peptide stimulation,
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Figure 6. Kinetic Analysis of Expansion and Cytokine Regulation of Perforin-Deficient NP118-Specific CD8 T Cells after LCMV Infection
BALB/c-PKO mice were infected with Att LM-NPs, and at day 80 p.i. mice were challenged with LCMV-Arm. The kinetics of NP118-specific
CD8 T cell response was determined by phenotypic and functional assays.
(A) At the indicated days prior and post-LCMV challenge, the frequencies of NP118-specific CD8 T cells in the spleen were determined by
MHC class I tetramer (Ld[NP118]) staining. The numbers inside the Ld(NP118) versus CD8 dot plots represent the percentage of all CD8 T cells/
percentage of NP118-specific CD8 T cells among all splenocytes. The numbers inside the numbers of cells versus Ld(NP118) histograms
represent the percentage of CD8 T cells that stained with Ld(NP118) tetramers.
(B) The total number of NP118-specific CD8 T cells per spleen determined by tetramer staining (filled squares). Data are presented as mean 
SD for two to three mice per time point. LOD represents the limit of detection. Survival of vaccinated BALB/c-PKO mice after LCMV infection
(open squares).
(C) At the indicated days post-LCMV challenge, the same mice as in (A) were analyzed for Ag-specific IFN or TNF production in the absence
(no peptide) or in the presence of NP118 peptide.
(D) Direct ex vivo cytokine production by wild-type (WT) and perforin-deficient NP118-specific CD8 T cells after LCMV infection. WT and BALB/
c-PKO mice were infected with Att LM-NPs and at day 58 p.i. mice were challenged with LCMV-Arm. At day 5 post-LCMV infection, splenocytes
from WT and BALB/c-PKO mice were stained with CD8 and tetramers (Ld[NP118]), fixed, permeabilized, and immediately stained for intracellular
IFN or TNF in the absence of peptide stimulation and BfA. Mean fluorescence indexes of CD8pos/Ld(NP118)neg and CD8pos/Ld(NP118)pos
populations are presented for both cytokines. Representative data from one mouse of two in one of three similar experiments are shown.
with an increase to 90% upon addition of the NP118 extinguished TNF due to continued Ag presentation.
However, given the relatively long incubation in vitro,peptide (Figure 6C). In sharp contrast, TNF production
by the same IFN-producing cells was not detected we cannot rule out the possibility that generation of a
single-cell suspension alters access of CD8 T cells towithout peptide stimulation and was minimal after addi-
tion of peptide. These data were consistent with the LCMV antigens or permits Ag display in vitro that was
absent in vivo.notion that NP118-specific CD8 T cells in BALB/c-PKO
mice were chronically stimulated to produce IFN but In order to determine whether cytokine dysregulation
Immunity
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BALB/c-PKO mice survived LCMV infection (Table 1).Table 1. Depletion of CD8Cells and Treatment with Anti-IFNNeu-
tralizing Antibodies Prevent Mortality of Vaccinated Perforin-Defi- In addition, two out of three Att LM-NPs vaccinated
cient Mice after LCMV Challenge BALB/c-PKO mice treated with anti-TNF neutralizing
mAb on day 5 after LCMV infection survived (data notInfection(s) Prior to LCMV
shown). Further experiments are needed in order toChallenge Treatment Mortality
show whether and under what instances anti-TNF treat-None None 0% (0/40)
ment might be beneficial to the host.Att LM None 0% (0/7)
Taken together, these data suggested that Ag-spe-Att LM-NPs / Rat IgG 88% (21/24)
Att LM-NPs CD8 0% (0/5) cific CD8 T cells were responsible for vaccination-
Att LM-NPs IFN 0% (0/7) induced mortality in the absence of perforin and that
cytokine production (IFN) by these cells was a majorBALB/c-PKO mice were infected with Att LM-NPs or Att LM strains
of LM and challenged with LCMV-Arm at least 50 days after initial factor that contributed to mortality after LCMV infection.
LM challenge. All antibodies were i.p. administered at 1 mg/mouse
on the day before LCMV challenge (CD8) or at day 5 post-LCMV Discussion
challenge (IFN). Survival was followed at least 30 days after LCMV
challenge. Data from multiple experiments are shown.
One hundred percent of naive BALB/c-PKO (H-2d MHC)
mice survived infection with LCMV-Arm. These mice
exhibited a vigorous NP118-specific CD8 T cell response,
could be observed without extensive incubation in bref- similar in magnitude to that observed in WT BALB/c,
eldin A, splenocytes from vaccinated BALB/c and BALB/ although LCMV was not cleared from BALB/c-PKO
c-PKO mice were obtained at 5 days post-LCMV-Arm hosts. As previously reported, NP118-specific CD8 T cells
infection and were immediately stained with Ld(NP118) undergo programmed contraction in BALB/c-PKO hosts
(tetramers) and then fixed and permeabilized before in- despite the high virus load in the spleen (Badovinac et
tracellular staining for IFN or TNF. Cytokine expression al., 2002). However, NP118-specific CD8 T cells were
was assessed by comparing the mean fluorescence be- eventually deleted (exhausted) by 85 days postinfection
tween tetramer-positive and -negative CD8 T cells. As in the BALB/c-PKO hosts. Thus, perforin was not essen-
predicted, no increase in cytokine levels was detected tial for CD8 T cell exhaustion after LCMV infection.
in BALB/c-derived NP118-specific CD8 T cells analyzed In previous studies, we used gene knockout mice as
directly ex vivo (Figure 6D). In contrast, direct ex vivo models for vaccination of immunocompromised hosts
IFN expression was observed in BALB/c-PKO-derived against infection with LM. Our results clearly showed
NP118-specific CD8 T cells (tetramer-positive) when that vaccination can overcome the absence of mole-
compared to the tetramer-negative CD8 T cells from cules, including perforin, that were essential for resis-
the same mice (Figure 6D). Interestingly, TNF was also tance of the naive host to bacterial infection (Harty and
detected in BALB/c-PKO-, but not BALB/c-derived, Badovinac, 2002). Thus, we sought to determine
NP118-specific CD8 T cells (Figure 6D). The reason(s) whether vaccination could protect perforin-deficient
why TNF production was detected by direct ex vivo hosts from persistent LCMV infection. However, rather
analysis and not after in vitro incubation remains to be than enhanced clearance, the majority (21/24) of vacci-
determined; however, these data suggested that nated BALB/c-PKO mice succumbed to LCMV by 8–9
chronic cytokine production by NP118-specific CD8 T days postinfection. These mice, which contained 105
cells occurred in vivo and contributed to mortality in LCMV-specific memory CD8 T cells/spleen (0.5%–1%
vaccinated BALB/c-PKO mice after LCMV infection. of CD8 T cells) at the time of infection, exhibited a
massive expansion of NP118-specific cells to levels that
represented 85%–90% of CD8 T cells in both lymphoidCD8 T Cells and Cytokines Contributed
to Mortality in Vaccinated Perforin-Deficient and nonlymphoid tissues by 5–6 days postinfection. By
this time, 108 NP118-specific CD8 T cells could beMice after LCMV-Arm Infection
In multiple experiments90% of Att LM-NPs vaccinated found in the spleen. Since the spleens of these mice
contained only 2  108 total cells, the NP118-specificBALB/c-PKO mice died by day 9 post-LCMV infection
(Table 1). The enormous expansion of NP118-specific CD8 T cells represented 50% of total spleen cells at
day 5 p.i. The spleen is thought to contain 25% of theCD8 T cells and dysregulated cytokine production cor-
related with mortality, but it was formally possible that total number of CD8 T cells in a mouse (Blattman et
al., 2002); thus, a conservative estimate would suggestthese elements of the immune system did not account
for mortality. In order to show that NP118-specific CD8 that each BALB/c-PKO animal contained 2  108
NP118-specific CD8 T cells. Thus, LCMV infection ofT cells were responsible for the observed mortality, vac-
cinated BALB/c-PKO mice were depleted of CD8 T cells vaccinated BALB/c-PKO mice essentially replaced the
normal diversity of the immune system with CD8 T cellsby antibody treatment prior to LCMV-Arm challenge.
Depletion of CD8 T cells prevented LCMV triggered specific for a single epitope.
In contrast to data obtained here with H-2d perforin-mortality. Thus, CD8 T cells were responsible for vacci-
nation-induced mortality in perforin-deficient mice (Ta- deficient mice, naive H-2b perforin-deficient mice (B6-
PKO) exhibited substantial, although not 100%, mortal-ble 1).
To address the contribution of cytokines to mortality, ity after primary LCMV infection (Gallimore et al., 1998;
Kagi et al., 1994, 1999; Matloubian et al., 1999; Walshwe administrated anti-IFN mAb on day 5 post-LCMV
challenge of Att LM-NPs vaccinated BALB/c-PKO mice. et al., 1994). Although the reason(s) for the strain differ-
ences is currently unknown, differences in the complex-Seven out of seven (anti-IFN treatment) vaccinated
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ity of the CD8 T cell response or the influence of back- three cells in the spleen at day 5 postinfection; data not
shown). Although additional experiments will be re-ground genes may account for the results. To determine
whether vaccine induced mortality in the absence of quired to determine whether the number of memory cells
determines the outcome after infection, these prelimi-perforin was generalizable to H-2b mice, we vaccinated
B6-PKO mice with recombinant Att LM that expressed nary data suggest that delivery of vaccine antigens by
LM is not required to sensitize vaccinated mice to LCMV-the LCMV GP33-41 (H-2Db restricted) epitope (van der Most
et al., 1996) and challenged with LCMV. All vaccinated induced mortality.
Recent in vitro studies revealed that cytokine produc-B6-PKO rapidly succumbed to LCMV infection (data not
shown). In addition, vaccinated B6-PKO mice showed tion by CD8 T cells was tightly regulated by the pres-
ence of Ag (IFN [Slifka et al., 1999; Badovinac et al.,massive and rapid GP33-specific CD8 T cell expansion
and dysregulated cytokine production after LCMV chal- 2000a]) or programmed to cease after a burst of produc-
tion even in the continued presence of Ag (TNF [Badovi-lenge (80% of CD8 T cells, representing 40% to 50%
of all cells in the spleen, were GP33-specific at day 6 nac et al., 2000a]). This tight regulation was suggested
to limit immunopathology and focus the CD8 T cellpostchallenge of vaccinated mice [data not shown]).
Therefore, vaccination also resulted in massive CD8 response on cells expressing pathogen-derived anti-
gens (Slifka and Whitton, 2000b). Consistent with thisT cell expansion and accelerated LCMV induced mortal-
ity in H-2b perforin-deficient mice. notion, CD8 T cells undergoing secondary expansion
in WT mice exhibited no direct ex vivo expression of eitherThe NP118-specific CD8 T cells from vaccinated
BALB/c-PKO mice exhibited abnormal regulation of IFN or TNF but rapidly produced both upon peptide
stimulation. In contrast, we showed that NP118-specificIFN and TNF in direct ex vivo assays, suggesting that
persistent infection led to overproduction of CD8T cell- CD8 T cells obtained from vaccinated BALB/c-PKO
mice at various times after LCMV infection producedderived cytokines and mortality in the absence of per-
forin. This notion was supported by rescue of vaccinated both IFN and TNF when analyzed directly ex vivo and
exhibited dysregulated cytokine production after in vitromice by treatment with neutralizing mAb for IFN. Impor-
tantly, depletion of CD8 T cells prior to LCMV infection culture in the absence of additional peptide stimulation.
Dysregulated cytokine production was also observedalso prevented death; thus, these cells were responsible
for vaccine-induced mortality. after DC immunization as well as in vaccinated B6-PKO
mice after LCMV infection (data not shown). Since theNaive and vaccinated BALB/c-PKO mice both fail to
clear LCMV infection. Why then do vaccinated mice levels of cytokine detected in the absence of stimulation,
brefeldin A, and prolonged incubation were modest, wesuccumb while naive mice survive? One major differ-
ence in the two situations was the number of NP118- could not tell whether only a subset of BALB/c-PKO-
derived NP118-specific CD8 T cells were producing cy-specific CD8 T cells present at the time of infection. It
is thought that the naive precursor pool for most CD8 tokines in vivo. However, given the enormous numbers
of NP118-specific CD8 T cells that respond to LCMVT cell epitopes consists of several hundred clones in
the spleen (Blattman et al., 2002). In contrast, vaccinated in vaccinated BALB/c-PKO mice, continuous cytokine
production from even a small fraction of cells couldBALB/c-PKO mice contained105 NP118-specific mem-
ory CD8 T cells/spleen at the time of LCMV infection. result in substantial immunopathology.
In addition to the role of perforin as an effector mole-Recent studies demonstrated that the magnitude of
CD8 T cell expansion after primary infection depended cule, experiments in various models such as chronic
LCMV infection (Binder et al., 1998; Gallimore et al.,on the number of precursors recruited into the response
(Kaech and Ahmed, 2001). Thus, the difference in avail- 1998; Matloubian et al., 1999), bone marrow transplanta-
tion/GVHD (Spaner et al., 1999), and autoimmunityable NP118-specific precursors in naive and vaccinated
perforin-deficient mice may have dictated survival or (Spielman et al., 1998) suggested a possible immunoreg-
ulatory role for perforin, perhaps specific for deletion ofdeath by controlling the eventual magnitude of the CD8
T cell response after infection. T cells in situations of chronic antigen exposure (Harty
and Badovinac, 2002). Although both vaccinated WTVaccinated BALB/c-PKO mice contained high levels
of memory cells, and it remains to be determined and BALB/c-PKO mice mount a significant secondary
CD8 T cell response to LCMV, the response in PKOwhether the number of memory cells dictates mortality
versus survival after LCMV infection. In addition, while mice is extraordinary, and only the perforin-deficient
mice succumb to infection. What specific role does per-LCMV-induced mortality required vaccination with LM
expressing the NP118 epitope, it is also possible that LM forin deficiency play in this process? We speculate that
the adverse outcome of LCMV infection in vaccinatedinfection helps to prime vaccinated mice for mortality.
The latter notion predicts that generation of NP118-spe- PKO mice results from a combination of perforin-regu-
lated events. First, the inability to rapidly clear LCMV bycific memory CD8 T cells using other vaccination strat-
egies would fail to sensitize BALB/c-PKO mice to LCMV- perforin-dependent cytolysis will result in a substantial
antigen load in PKO mice. In turn, this will ensure thatinduced mortality. In direct contrast to this notion,30%
(two out of seven) BALB/c-PKO mice that contained most, if not all, NP118-specific memory CD8 T cells are
recruited to undergo a programmed degree of expan-NP118-specific CD8 T cells generated after vaccination
with peptide-coated dendritic cells (Hamilton and Harty, sion (Kaech and Ahmed, 2001), generating massive
numbers of CD8 T cells. In contrast, WT memory CD82002) succumbed to LCMV infection. These mice, which
had 1  104 NP118 memory CD8 T cells/spleen prior T cells rapidly control LCMV infection, limiting the
amount of antigen and likely causing only a subset ofto infection (10- to 20-fold fewer than the Att LM-NPs
vaccinated mice), also exhibited massive expansion of memory cells to be recruited into the secondary re-
sponse. This notion is consistent with data demonstra-LCMV-specific CD8 T cells (approximately one out of
Immunity
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ting that primary and secondary responses are of similar cient individuals with familial hemophagocytic lympho-
magnitude in WT mice after LCMV infection (Grayson histiocytosis (de Saint Basile and Fischer, 2001; Stepp
et al., 2002). et al., 1999; Trapani and Smyth, 2002).
In addition to the massive expansion, CD8 T cells in
Experimental Proceduresvaccinated PKO mice would be subjected to chronic
antigen exposure since the virus was not cleared. Al-
Mice
though our results with naive BALB/c-PKO mice showed BALB/c (H-2d MHC) mice were obtained from the National Cancer
that perforin was not essential for exhaustive deletion Institute (Frederick, MD). BALB/c-PKO mice (H-2d MHC) were pre-
of NP118-specific CD8 T cells, complete elimination of viously described (Badovinac et al., 2000b; White et al., 1999). BALB/
c-PKO mice were maintained by brother-sister mating and housedthese cells required several months as opposed to the
under specific pathogen-free conditions at the University of Iowarelatively short period of time required to eliminate WT
(Iowa City, IA) animal care unit until the initiation of the experimentsAg-specific cells after chronic LCMV infection (Zajac et
with LCMV and/or LM, at which point the mice were transferred toal., 1998). Extended survival of perforin-deficient CD8
standard housing at the appropriate biosafety level. All mice were
T cells, based on increased resistance to AICD in the used at 8–16 weeks of age.
face of chronic antigen exposure, could also contribute
to cytokine dysregulation and mortality in vaccinated Bacteria, Virus, and Immunization
Virulent LM strain XFL303 (NP118-expressing strain; Vir LM-NPsPKO mice.
[Shen et al., 1998] and attenuated [actA-deficient] LM strains DP-Differential survival after LCMV infection of naive and
L1942 [Att LM] [Brundage et al., 1993]) and XFL303actA- (Att LM-vaccinated BALB/c-PKO mice could also result from
NPs) (Tvinnereim et al., 2002) are resistant to streptomycin and
unique properties of CD8 T cells undergoing primary were used as previously described (Harty and Bevan, 1995). In brief,
and secondary responses to infection. It has long been frozen stocks of bacteria were diluted in a tryptic soy broth and
known that activation of memory CD8 T cells is less grown in a bacterial shaker at 37C to an OD600 of0.1 (108 cfu/ml),
diluted in pyrogen-free 0.9% sodium chloride (Abbott Laboratories,dependent on costimulatory signals than activation of
North Chicago, IL), and injected i.v. in a 0.2 ml volume/animal. Ali-naive CD8 T cells. In addition, recent evidence showed
quots were plated onto tryptic soy agar containing 50 	g/ml ofthat WT CD8 T cells underwent programmed contrac-
streptomycin (TSB-Strep) to verify the number of cfu injected. Thetion after primary infection that was rapid, with the ma-
Armstrong strain of LCMV (2  105 pfu/mouse; intraperitoneally)
jority of CD8 T cell death occurring within 3–5 days after was used as previously described (Badovinac et al., 2000b). Viral
the peak of expansion and independently of pathogen titers in homogenates of spleen and lungs were determined by
clearance or Ag display (Badovinac et al., 2002). In con- plaque assay on VERO cells as described (Shen et al., 1998).
trast, while the program of contraction in the secondary
Monoclonal Antibodies and PeptidesCD8 T cell response was also set by early events after
The following mAbs were used: IFN-PE or FITC (clone XMG 1.2,infection, these cells exhibited a substantially delayed
eBioscience, San Diego, CA), TNF-PE or FITC (clone MP6-XT22,contraction phase, which took several weeks to reach eBioscience), CD8-FITC or CyChrome (clone 53-6.7, PharMingen,
secondary memory levels (Badovinac et al., 2002; Gray- San Jose, CA). Synthetic peptides representing the defined LCMV
son et al., 2002). It remains to be determined whether (NP118-126 H-2Ld restricted; van der Most et al., 1996) or LM (LLO91-99
and p60217-225 H-2Kd restricted; Harty and Pamer, 1995; Pamer et al.,the secondary response of perforin-deficient CD8 T cells
1991) epitopes were synthesized at the University of Iowa Proteinalso undergoes prolonged contraction and whether this
Structure Facility. In vivo CD8 T cell depletion and IFN or TNFfeature of memory CD8 T cells facilitates immunopa-
neutralization were performed at the indicated days before or afterthology during chronic infection. In addition, CD8 T cell
LCMV-Arm infection by injection of anti-CD8 mAb 2.43, anti-IFN
exhaustion in the LCMV model has only been shown mAb XMG1.2 (Harty and Bevan, 1995), and anti-TNF mAb XT22
after primary infection, using strains or doses of LCMV (White and Harty, 1998). All antibodies, including rat IgG (Sigma),
that cause chronic infections in naive WT mice. In con- were administred intraperitoneally at 1 mg/mouse.
trast, memory CD8 T cells in vaccinated WT mice rap-
Quantification of Ag-Specific CD8 T Cells in the Spleenidly clear even these LCMV strains. Perhaps memory
The magnitude of the epitope-specific CD8 T cell response wasCD8 T cells were more resistant to exhaustion, and
determined by intracellular cytokine staining (ICS) for TNF and/orthis property determined mortality in vaccinated BALB/
IFN after 6 hr of incubation in brefeldin A (BfA; PharMingen), in the
c-PKO mice. presence or absence of peptide, or by MHC class I tetramer staining
The concept of “vaccination for disease” was based as previously described (Badovinac et al., 2000a; Badovinac and
on studies showing perforin-mediated meningitis in vac- Harty, 2000). For ICS, the percent of TNF or IFN CD8 T cells in
the unstimulated sample for each mouse was subtracted from thecinated but not control mice after IC infection with cer-
peptide-stimulated value to determine the frequency of Ag-specifictain LCMV strains (Oehen et al., 1992). Our results
CD8 T cells. Total number of epitope-specific CD8 T cells pershowed that vaccination of perforin-deficient hosts with
spleen was calculated from this frequency, the percent of CD8a single LCMV epitope converted a nonlethal peripheral
T cells in each sample, and total number of cells per spleen. In
infection into devastating disease mediated by CD8 experiments where ICS was performed directly ex vivo, splenocytes
T cell-derived cytokines. Thus, at least in some cases, from LCMV-Arm-infected mice were stained immediately with MHC
vaccination of immunocompromised individuals could class I tetramers and CD8 mAb for 1 hr on ice, fixed, and permeabil-
ized with Cytofix/Cytoperm solution (PharMingen) before the addi-be counterproductive, even if these individuals tolerated
tion of IFN or TNF mAbs.the initial vaccine. Rescue of vaccinated mice from
LCMV-induced mortality with neutralizing mAb specific
Isolation of Lymphocytes from Tissuesfor IFN not only identified an important effector mole-
Prior to tissue removal, samples of blood were obtained by retroor-
cule for mortality but also suggested that transient inhi- bital puncture. Anesthetized mice were then perfused in the left
bition of cytokine bioactivity could rescue mice from ventricle with phosphate-buffered saline containing 70 U/ml heparin
cytokine-mediated immunopathology. This finding (Sigma). Tissues (liver, lung, kidney) were cut into small pieces and
incubated at 37C for 90 min in collagenase (150 U/ml) (Gibco-could have implications for treatment of perforin-defi-
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BRL, Rockville, MD) in RPMI with 5% fetal calf serum. The resulting de Saint Basile, G., and Fischer, A. (2001). The role of cytotoxicity
in lymphocyte homeostasis. Curr. Opin. Immunol. 13, 549–554.mixture was made into a single-cell suspension, filtered, and
washed. Liver and kidney cell suspensions were underlaid with a Fulginiti, V.A., Eller, J.J., Downie, A.W., and Kempe, C.H. (1967).
35% Percoll (Sigma) solution and lung cell suspensions were under- Altered reactivity to measles virus. Atypical measles in children pre-
laid with both a 40% and 75% Percoll solution. Samples were centri- viously immunized with inactivated measles virus vaccines. JAMA
fuged at 2500 rpm for 20 min at room temperature. The single inter- 202, 1075–1080.
face of lymphocytes from liver and kidney preparations and the Gallimore, A., Glithero, A., Godkin, A., Tissot, A.C., Pluckthun, A.,
lower interface of lung lymphocytes were collected and treated with Elliott, T., Hengartner, H., and Zinkernagel, R. (1998). Induction and
Tris-ammonium chloride to remove red blood cells and then washed exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic
extensively before staining with MHC class I tetramers and CD8 T lymphocytes visualized using soluble tetrameric major histocom-
mAb. Bone marrow cells were obtained from femurs as previously patibility complex class I peptide complexes. J. Exp. Med. 187,
described (Hamilton and Harty, 2002). Single-cell suspensions from 1383–1393.
spleen and bone marrow were treated with Tris-ammonium chloride
Goldrath, A.W., and Bevan, M.J. (1999). Selecting and maintainingand washed prior to tetramer staining.
a diverse T-cell repertoire. Nature 402, 255–262.
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